Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HoxBlinc lncRNA reprograms CTCF-independent TADs to drive leukemic transcription and HSC dysregulation in NUP98-rearranged leukemia
Karina Hamamoto, … , Mingjiang Xu, Suming Huang
Karina Hamamoto, … , Mingjiang Xu, Suming Huang
Published January 30, 2025
Citation Information: J Clin Invest. 2025;135(7):e184743. https://doi.org/10.1172/JCI184743.
View: Text | PDF
Research Article Genetics Hematology

HoxBlinc lncRNA reprograms CTCF-independent TADs to drive leukemic transcription and HSC dysregulation in NUP98-rearranged leukemia

  • Text
  • PDF
Abstract

Although nucleoporin 98 (NUP98) fusion oncogenes often drive aggressive pediatric leukemia by altering chromatin structure and expression of homeobox (HOX) genes, underlying mechanisms remain elusive. Here, we report that the Hoxb-associated lncRNA HoxBlinc was aberrantly activated in NUP98-PHF23 fusion–driven leukemias. HoxBlinc chromatin occupancies led to elevated mixed-lineage leukemia 1 (MLL1) recruitment and aberrant homeotic topologically associated domains (TADs) that enhanced chromatin accessibilities and activated homeotic/hematopoietic oncogenes. HoxBlinc depletion in NUP98 fusion–driven leukemia impaired HoxBlinc binding, TAD integrity, MLL1 recruitment, and the MLL1-driven chromatin signature within HoxBlinc-defined TADs in a CCCTC-binding factor–independent (CTCF-independent) manner, leading to inhibited homeotic/leukemic oncogenes that mitigated NUP98 fusion–driven leukemogenesis in xenografted mouse models. Mechanistically, HoxBlinc overexpression in the mouse hematopoietic compartment induced leukemias resembling those in NUP98-PHF23–knockin (KI) mice via enhancement of HoxBlinc chromatin binding, TAD formation, and Hox gene aberration, leading to expansion of hematopoietic stem and progenitor cell and myeloid/lymphoid cell subpopulations. Thus, our studies reveal a CTCF-independent role of HoxBlinc in leukemic TAD organization and oncogene-regulatory networks.

Authors

Karina Hamamoto, Ganqian Zhu, Qian Lai, Julia Lesperance, Huacheng Luo, Ying Li, Nupur Nigam, Arati Sharma, Feng-Chun Yang, David Claxton, Yi Qiu, Peter D. Aplan, Mingjiang Xu, Suming Huang

×

Figure 1

HoxBlinc lncRNA is highly activated and binds to Hoxa/b in NUP98-PHF23–driven leukemia.

Options: View larger image (or click on image) Download as PowerPoint

HoxBlinc lncRNA is highly activated and binds to Hoxa/b in NUP98-PHF23–...
(A) Heatmap of the z score in normalized differentially expressed genes (DEGs) by DEseq2 in RNA-Seq (961C vs. BaF3). DEGs were selected according to a log2(fold change) of greater than 1 and an FDR of less than 0.05. (B) GSEA of DEGs using the TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_ 16D_UP (M15588) gene set and the PARK_HSC_MARKERS (M6509) gene set. (C) Mouse HoxBlinc expression levels in BaF3 and 961C cells were determined by RT-qPCR. Data are presented as the mean ± SD from three independent experiments. **P ≤ 0.01, by 2-tailed, unpaired Student’s t test. (D) Pie chart of global HoxBlinc ChIRP-Seq distribution in 961C B-ALL cells carrying the NUP98-PHF23 fusion (60,571 peaks). (E) RNA-Seq, ATAC-Seq, H3K4me3 CUT&RUN, HoxBlinc ChIRP-Seq, and CTCF/NUP98-PHF23-V5 ChIP-Seq analysis of changes in RNA levels, chromatin accessibility, H3K4me3 modification levels, HoxBlinc lncRNA, and CTCF and NUP98-PHF23 bindings at Hoxa and Hoxb loci in BaF3 versus NUP98-PHF23–KI 961C cells. The HoxBlinc-transcribed region is enlarged. HoxBlinc-defined active TADs/sub-TADs at Hoxa/b loci are highlighted in yellow. (F) Top: Overlapping of RNA-upregulated genes in 961C cells with HoxBlinc binding at the promoter (within 3 kb). Bottom left: GO analysis of 1,010 overlapping genes. Bottom right: Database for Annotation, Visualization, and Integrated Discovery (DAVID) GO functional annotation enrichment analysis of 1,010 overlapping genes. Ant./post., anterior/posterior; Pos. reg., positive regulation.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts